THE PENNANT GROUP, INC. Increase (Decrease) in Accounts Receivable
THE PENNANT GROUP, INC. (PNTG) reported Increase (Decrease) in Accounts Receivable of $7.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05
- THE PENNANT GROUP, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $7.72M, a 734.70% increase year-over-year.
- THE PENNANT GROUP, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $35.00K, a 99.75% decline year-over-year.
- THE PENNANT GROUP, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $8.75M.
- THE PENNANT GROUP, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $591.00K, a 92.71% decline year-over-year.
- THE PENNANT GROUP, INC. increase (decrease) in accounts receivable for fiscal 2025 was $24.15M, a 14.51% increase from fiscal 2024.
- THE PENNANT GROUP, INC. increase (decrease) in accounts receivable for fiscal 2024 was $21.09M, a 186.91% increase from fiscal 2023.
- THE PENNANT GROUP, INC. increase (decrease) in accounts receivable for fiscal 2023 was $7.35M, a 1936.01% increase from fiscal 2022.
- THE PENNANT GROUP, INC. increase (decrease) in accounts receivable for fiscal 2022 was $361.00K, a 95.08% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $7.76M 10-Q · filed 2026-08-05 | $16.50M derived: sum of 3 quarters · filed 2026-08-05 | $17.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $35.00K 10-Q · filed 2026-05-06 | $8.78M derived: sum of 2 quarters · filed 2026-05-06 | $9.37M derived: sum of 3 quarters · filed 2026-05-06 | $10.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $8.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.34M derived: sum of 2 quarters · filed 2026-02-26 | $10.26M derived: sum of 3 quarters · filed 2026-08-05 | $24.15M 10-K · filed 2026-02-26 |
| 2025-09-30 | $591.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.52M derived: sum of 2 quarters · filed 2026-08-05 | $15.40M 10-Q · filed 2025-11-05 | $12.96M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $925.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $14.81M 10-Q · filed 2026-08-05 | $12.37M derived: sum of 3 quarters · filed 2026-08-05 | $20.47M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $13.88M 10-Q · filed 2026-05-06 | $11.44M derived: sum of 2 quarters · filed 2026-05-06 | $19.54M derived: sum of 3 quarters · filed 2026-05-06 | $24.49M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.66M derived: sum of 2 quarters · filed 2026-02-26 | $10.61M derived: sum of 3 quarters · filed 2026-02-26 | $21.09M 10-K · filed 2026-02-26 |
| 2024-09-30 | $8.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $13.05M derived: sum of 2 quarters · filed 2025-11-05 | $23.53M 10-Q · filed 2025-11-05 | $25.32M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $4.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $15.43M 10-Q · filed 2025-08-06 | $17.22M derived: sum of 3 quarters · filed 2026-02-26 | $20.15M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $10.48M 10-Q · filed 2025-05-06 | $12.27M derived: sum of 2 quarters · filed 2026-02-26 | $15.20M derived: sum of 3 quarters · filed 2026-02-26 | $21.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.72M derived: sum of 2 quarters · filed 2026-02-26 | $10.52M derived: sum of 3 quarters · filed 2026-02-26 | $7.35M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $8.73M derived: sum of 2 quarters · filed 2024-11-06 | $5.56M 10-Q · filed 2024-11-06 | $7.66M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $5.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $2.63M 10-Q · filed 2024-08-06 | $4.73M derived: sum of 3 quarters · filed 2025-02-27 | $3.40M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$3.17M 10-Q · filed 2024-05-06 | -$1.07M derived: sum of 2 quarters · filed 2025-02-27 | -$2.40M derived: sum of 3 quarters · filed 2025-02-27 | -$5.97M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $767.00K derived: sum of 2 quarters · filed 2025-02-27 | -$2.80M derived: sum of 3 quarters · filed 2025-02-27 | $361.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | -$1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$4.89M derived: sum of 2 quarters · filed 2023-11-07 | -$1.73M 10-Q · filed 2023-11-07 | -$1.11M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$3.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$406.00K 10-Q · filed 2023-08-08 | $221.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.57M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $3.16M 10-Q · filed 2023-05-04 | $3.79M derived: sum of 2 quarters · filed 2024-02-28 | $5.14M derived: sum of 3 quarters · filed 2024-02-28 | $6.70M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $627.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.98M derived: sum of 2 quarters · filed 2024-02-28 | $3.54M derived: sum of 3 quarters · filed 2024-02-28 | $7.33M 10-K · filed 2024-02-28 |
| 2021-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $2.91M derived: sum of 2 quarters · filed 2022-11-07 | $6.71M 10-Q · filed 2022-11-07 | $18.22M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $5.36M 10-Q · filed 2022-08-08 | $16.87M derived: sum of 3 quarters · filed 2023-02-23 | $19.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $3.79M 10-Q · filed 2022-05-09 | $15.31M derived: sum of 2 quarters · filed 2023-02-23 | $17.43M derived: sum of 3 quarters · filed 2023-02-23 | $15.84M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $11.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $13.63M derived: sum of 2 quarters · filed 2023-02-23 | $12.05M derived: sum of 3 quarters · filed 2023-02-23 | $15.71M 10-K · filed 2023-02-23 |
| 2020-09-30 | $2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $537.00K derived: sum of 2 quarters · filed 2021-11-08 | $4.20M 10-Q · filed 2021-11-08 | $6.36M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $2.08M 10-Q · filed 2021-08-09 | $4.24M derived: sum of 3 quarters · filed 2022-02-28 | $6.95M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $3.66M 10-Q · filed 2021-05-06 | $5.83M derived: sum of 2 quarters · filed 2022-02-28 | $8.54M derived: sum of 3 quarters · filed 2022-02-28 | $10.12M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $4.88M derived: sum of 2 quarters · filed 2022-02-28 | $6.46M derived: sum of 3 quarters · filed 2022-02-28 | $8.57M 10-K · filed 2022-02-28 |
| 2019-09-30 | $2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $4.30M derived: sum of 2 quarters · filed 2020-11-10 | $6.41M 10-Q · filed 2020-11-10 | $6.54M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $3.69M 10-Q · filed 2020-08-11 | $3.82M derived: sum of 3 quarters · filed 2021-02-24 | |
| 2019-03-31 | $2.11M 10-Q · filed 2020-05-13 | $2.24M derived: sum of 2 quarters · filed 2021-02-24 | ||
| 2018-12-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $2.57M 10-K · filed 2021-02-24 | ||
| 2018-09-30 | $2.44M 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | $5.71M 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |